![](/img/cover-not-exists.png)
Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study
Robak, Tadeusz, Huang, Huiqiang, Jin, Jie, Zhu, Jun, Liu, Ting, Samoilova, Olga, Pylypenko, Halyna, Verhoef, Gregor, Siritanaratkul, Noppadol, Osmanov, Evgenii, Pereira, Juliana, Mayer, Jiri, Hong, XiLanguage:
english
Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2017.1321750
Date:
June, 2017
File:
PDF, 1.15 MB
english, 2017